Morbidity Low With Focal Laser Ablation of Prostate Cancer

FRIDAY, April 12, 2019 -- Focal laser ablation (FLA) of low- to intermediate-risk prostate cancer is associated with low morbidity and good oncologic outcomes, according to a study published in the March issue of the Journal of Vascular and...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news